DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
82.04
+0.43 (0.53%)
Nov 17, 2026, 4:00 PM EST - Market closed
DexCom Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, DexCom stock has a consensus rating of "Strong Buy" and an average price target of $98.58. The average 1-year stock price forecast is 20.16% higher than the current stock price, while the lowest is $79 (-3.71%) and the highest is $120 (+46.27%).
Price Target: $98.58 (+20.16%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 22 | 22 | 22 | 22 | 22 | 22 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 28 | 28 | 28 | 29 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $87 → $94 | Buy | Maintains | $87 → $94 | +14.58% | Nov 2, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $82 → $85 | Hold | Reiterates | $82 → $85 | +3.61% | Oct 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $95 | Buy | Reiterates | $95 | +15.80% | Oct 30, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $95 | Buy | Reiterates | $95 | +15.80% | Oct 30, 2026 |
| Raymond James | Raymond James | Buy Maintains $94 → $97 | Buy | Maintains | $94 → $97 | +18.24% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
5.23B
from 4.66B
Increased by 12.15%
Revenue Next Year
5.77B
from 5.23B
Increased by 10.45%
EPS This Year
2.70
from 2.09
Increased by 29.22%
EPS Next Year
3.13
from 2.70
Increased by 16.08%
EPS and Forward PE are based on non-GAAP adjusted numbers.